As Editor-in-Chief of Drug and Alcohol Dependence Reports (DADR), I welcome you to our journal, a companion journal to the well-established and well-respected international addiction journal, Drug and Alcohol Dependence (DAD). I hail from University of Pennsylvania Perelman School of Medicine, at the Center for Studies of Addiction within the Department of Psychiatry, in Philadelphia, Pennsylvania (United States). My broad interests include both clinical and preclinical research in substance use disorders, including neuroscience, psychiatric comorbidity, behavioral pharmacology, medications development, clinical trials and behavioral interventions. My goal is to introduce you to the journal so if you want to learn more about me you can read a short biography at Penn Psychiatry.
DADR offers an alternative home for high quality, methodologically sound addiction science. DADR maintains the expansive coverage of all areas of research related to the study of drug dependence such as that published in DAD. However, we seek to broaden the scope of DAD by offering a home to research that may be nuanced, or have a narrow focus (i.e., specific populations, novel drugs), as well as include reports that may be considered preliminary, exploratory, novel or pilot. Also, DADR will expand upon the types of articles that will be accepted. Thought-provoking or intriguing short communications and letters to the editor are evaluated. Areas of research that are not commonly evaluated by DAD, such as gaming, gambling, obesity and other nondrug dependencies are evaluated.
We are also committed to developing a diverse client base at all levels (i.e., authors, reviewers, editorial board members, and associate editors). Diverse groups experience discrimination at all levels in the scientific process. We will take additional steps towards minimizing discriminatory practices, which will reflect upon our readership. These steps will include aiding young/new investigators, who also experience scientific discrimination, to publish meritorious science. DADR is owned by Elsevier and will receive the same expert guidance, support and platforms as DAD. We are also affiliated with the College on Problems of Drug Dependence (CPDD). DADR is 100% Open Access (OA) and OA fees are currently being waived. So, submit your manuscript soon! Visit our Science Direct Page to read our full Aims and Scope.
In under six short months, our DADR team has worked hard and successfully to get this first issue out to you and the scientific community. I would like to take this opportunity to introduce and thank our team members. Scott Whitener is our Elsevier Senior Publisher, who is passionate about the success of our journal and keeps the momentum going. Sue Hurren is our Elsevier Journal Manager who is guiding us to shape and tighten the submission process and who responds to my every query ...and there are many. Our Associate Editor is Sherry Mckee, PhD, whose home is Yale University. Her contribution to the journal is invaluable and I am thrilled to be working with her. I would also like to introduce Walter Roberts, PhD, also from Yale, our Social Media Editorial Intern who will utilize social media platforms to disseminate our science. To keep this brief, I guide you to our Science Direct Page to peruse our expanding portfolio of Editorial and Advisory Board members, many of whom also serve as Associate Editors and Editorial Board members for DAD. We can't say enough how appreciative we are for the role they fill in lending their trusted names and expertise, providing confidence in our journal to prospective authors across the globe.
I would also like to take this opportunity to express my gratitude for those who were instrumental in choosing me to fill the role of Editor-in-Chief. I will start by conveying my sincere thanks to Linda Porrino, PhD, Wake Forrest University (Associate Editor, DAD) and Eric Strain, MD, Johns Hopkins University (Editor-in-Chief, DAD) for training and support over the past year. Dr. Porrino and Dr. Strain have been and continue to be incredibly responsive and helpful as I learn the ropes of the position. I am also thankful and quite frankly, humbled, by the efforts of the Editor-in-Chief Search Committee of CPDD for identifying me as a potential candidate for an editorial position with Elsevier. On that note, I send out a special thank you to Amy Janes, PhD, National Institute on Drug Abuse (President-Elect, CPDD), and Bill Stoops, PhD, University of Kentucky (President, CPDD) who were especially supportive of me in their roles on the committee. I would also like to convey my thanks to Agnieszka Freda, Senior Publisher, Elsevier who showed exceptional professionalism and expertise, and yet was extraordinarily friendly and kind throughout the interview process. She was also instrumental in the final decision to grant me the role and for that I am also thankful. I also want to send a thank you out to all of the authors who have submitted manuscripts. Your submissions are the cogs that spin the journal's wheels, and we are very grateful for your trust and support.
We hope you enjoy the first edition of DADR.
In Science and Health, Teri Franklin, PhD.